Lisata Therapeutics Inc. (LSTA) — Capital Reinvestment Ratio
Latest as of June 2020:
0.00x
Lisata Therapeutics Inc. (LSTA) has a Capital Reinvestment Ratio of 0.00x as of June 2020, meaning it reinvests 0% of its operating cash flow ($4.50 Million) in capital expenditures ($12.00K). See Lisata Therapeutics Inc. (LSTA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$4.50 Million
USD
Capital Expenditures
$12.00K
USD
Data as of
Jun 2020
Most recent filing
Lisata Therapeutics Inc. Capital Reinvestment Ratio (1992–2002)
This chart tracks Lisata Therapeutics Inc.'s Capital Reinvestment Ratio across 3 annual periods.
Annual Capital Reinvestment Ratio for Lisata Therapeutics Inc. (1992–2002)
Year-by-year Capital Reinvestment Ratio for Lisata Therapeutics Inc. from 1992 to 2002. For live market cap and broader valuation context, see Lisata Therapeutics Inc. stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2002 | 0.00x | $1.01 Million | $1.13K | ▼ -99.9% |
| 1993 | 1.06x | $470.00K | $500.00K | ▲ +219.1% |
| 1992 | 0.33x | $240.00K | $80.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow